Ares Management Launches Automated Industrial Robotics Inc.
Ares Private Equity Fund Invests Substantial Equity Capital to Support AIR’s Growth Strategy AIR Acquires TA Systems and Modular AutomationLOS...
Day: January 25, 2024
Red Light Holland Announces Strategic Changes and Launch of SR Wholesale North America, a Fresh Mushroom Sales Division
Toronto, Ontario--(Newsfile Corp. - January 25, 2024) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light...
Liviniti and Mark Cuban Cost Plus Drug Company Team Up for More Affordable Prescription Drugs
Industry-leading PBM, Liviniti, adds Mark Cuban Cost Plus Drug Company to its network of pharmacy options for membersNatchitoches, Louisiana--(Newsfile Corp....
Berenson Acquisition Corp. I Receives Noncompliance Notification from the New York Stock Exchange Regarding Minimum Public Stockholders
New York, New York--(Newsfile Corp. - January 25, 2024) - Berenson Acquisition Corp. I (NYSE American: BACA) (the "Company") announced...
PolarSeal(R) Joins Industry Pioneers at MD&M West 2024 for a Showcase of Excellence
PolarSeal®, a pioneering force in advanced manufacturing, proudly announces its participation in the highly anticipated MD&M West 2024, a premier...
Congressman James E. Clyburn and Vision to Learn Founder Austin Beutner Address National Vision Care Crisis Among School Children
More than 3 million children across the country go to school every day without the glasses they need. The need...
Dog Study Published in PLOS ONE Shows Statistically Significant Results for Use of Jaguar Health’s Crofelemer for Preventive Treatment of Cancer Therapy-Related Diarrhea (CTD)
This study, conducted by Jaguar family company Napo Pharmaceuticals in collaboration with Puma Biotechnology, is one of three important studies...
Ursamin CEO and Founder Joins Nashville Entrepreneur Center 2024 Project Healthcare Cohort
Project Healthcare Program Shines with Record of Fostering Innovation in HealthcareFAYETTEVILLE, NY / ACCESSWIRE / January 25, 2024 / Ursamin,...
Caspar.AI Launches Contactless Vitals & Real-time Bed Monitoring Solutions with Arcadia, Shellpoint, and Melur Meadows
Revolutionizing remote healthcare with Ambient AIPALO ALTO, CA / ACCESSWIRE / January 25, 2024 / Caspar.AI, an innovator in AI-driven...
Shifox Re-Brands as Alopex and Announces Completion of Investment Round
Completion of Recent Funding Round Allows Alopex to Expand Staff and Enhance TechnologyLAS VEGAS, NV / ACCESSWIRE / January 25,...
PMD Informs About the Record Date and Procedure of Reverse Split of Shares
STOCKHOLM, SWEDEN / ACCESSWIRE / January 25, 2024 / PMD Device Solutions (STO:PROMO)(FRA:8T0) At PMD's General Meeting on December 29,...
Castellum Announces Pricing of $2.7 Million Registered Direct Offering
Castellum Announces Pricing of $2.7 Million Registered Direct Offering Castellum, Inc. (the “Company”) (NYSE-American: CTM), a cybersecurity, electronic warfare, and...
SELLAS Life Sciences to Present SLS009 Phase 1 Data from Acute Myeloid Leukemia Patients at the 2024 European School of Haematology (ESH) Conference
NEW YORK, Jan. 25, 2024 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS” or the “Company”), a...
Bright Green Corporation announces the agreement to acquire platform technologies and associated intellectual property from C2 Wellness Corp.
Grants, New Mexico, Jan. 25, 2024 (GLOBE NEWSWIRE) -- Bright Green Corporation (NASDAQ: BGXX) today announced the agreement to purchase...
Windtree Eliminates $15 Million Contingent Liability to Deerfield Management Company
WARRINGTON, Pa., Jan. 25, 2024 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company...
NightHawk’s Scorpius BioManufacturing Subsidiary Awarded Multimillion- Dollar Contract with a Publicly Traded Biotech Company to Support its Phase 2 Clinical Program
Project to benefit from Scorpius’ comprehensive services in process development, bioanalysis, and cGMP manufacturingDURHAM, N.C., Jan. 25, 2024 (GLOBE NEWSWIRE)...
Intelligent Bio Solutions Inc. Announces Reverse Stock Split
NEW YORK, Jan. 25, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“Intelligent Bio Solutions” or the “Company”), a medical...
Processa Pharmaceuticals Announces Successful Completion of Phase 1b Safety Evaluation of NGC-Cap in Patients with Advanced Cancer Resulting in Recommended Phase 2 Doses
Next Generation Capecitabine (NGC-Cap) provides patients with 2-10 times greater exposure to its 5-FU cancer treatment metabolite than capecitabine administration...
Veru to Report Fiscal 2024 First Quarter Financial Results on February 8, 2024
MIAMI, FL, Jan. 25, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on...
Organovo Presents FXR314 3D Human Tissue Model Findings That Show Improved Epithelial Barrier Function and Fibrosis Reduction at Crohn’s and Colitis Congress
SAN DIEGO, Jan. 25, 2024 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO), a clinical stage biotechnology company focused on...